Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE1 SYNE3 SYNE2	1.48e-06	5	107	3	GO:0140444
GeneOntologyCellularComponent	microtubule organizing center attachment site	SYNE1 SYNE3 SYNE2	2.09e-05	11	107	3	GO:0034992
GeneOntologyCellularComponent	meiotic nuclear membrane microtubule tethering complex	SYNE1 SYNE3 SYNE2	2.09e-05	11	107	3	GO:0034993
GeneOntologyCellularComponent	nuclear membrane protein complex	SYNE1 SYNE3 SYNE2	2.09e-05	11	107	3	GO:0106083
GeneOntologyCellularComponent	nuclear membrane microtubule tethering complex	SYNE1 SYNE3 SYNE2	2.09e-05	11	107	3	GO:0106094
GeneOntologyCellularComponent	centriolar satellite	CEP162 KIAA0753 PJA2 SSX2IP PATJ	5.14e-04	128	107	5	GO:0034451
Domain	KASH	SYNE1 SYNE3 SYNE2	6.88e-07	4	105	3	IPR012315
Domain	KASH	SYNE1 SYNE3 SYNE2	6.88e-07	4	105	3	PS51049
Domain	KASH	SYNE1 SYNE3 SYNE2	6.88e-07	4	105	3	SM01249
Domain	KASH	SYNE1 SYNE3 SYNE2	6.88e-07	4	105	3	PF10541
Domain	ZF_CCHC_HIVEP	HIVEP1 HIVEP3	3.13e-05	2	105	2	PS51811
Domain	Cadherin_CS	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	3.46e-05	109	105	6	IPR020894
Domain	CADHERIN_1	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	4.25e-05	113	105	6	PS00232
Domain	Cadherin	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	4.25e-05	113	105	6	PF00028
Domain	CADHERIN_2	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	4.46e-05	114	105	6	PS50268
Domain	-	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	4.46e-05	114	105	6	2.60.40.60
Domain	CA	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	4.69e-05	115	105	6	SM00112
Domain	Cadherin-like	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	4.92e-05	116	105	6	IPR015919
Domain	Cadherin	DSG2 PCDHGA10 PCDH11Y CDH3 CDH4 PCDH18	5.41e-05	118	105	6	IPR002126
Domain	DEK_C	SSH1 SSH3	1.86e-04	4	105	2	PF08766
Domain	DEK_C	SSH1 SSH3	1.86e-04	4	105	2	IPR014876
Domain	Spectrin	SYNE1 SYNE3 SYNE2	2.82e-04	23	105	3	PF00435
Domain	Cadherin_C	DSG2 CDH3 CDH4	3.63e-04	25	105	3	PF01049
Domain	Cadherin_cytoplasmic-dom	DSG2 CDH3 CDH4	3.63e-04	25	105	3	IPR000233
Domain	Catenin_binding_dom	DSG2 CDH3 CDH4	5.67e-04	29	105	3	IPR027397
Domain	Spectrin_repeat	SYNE1 SYNE3 SYNE2	5.67e-04	29	105	3	IPR002017
Domain	-	DSG2 CDH3 CDH4	5.67e-04	29	105	3	4.10.900.10
Domain	SPEC	SYNE1 SYNE3 SYNE2	7.61e-04	32	105	3	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SYNE3 SYNE2	7.61e-04	32	105	3	IPR018159
Domain	Cadherin_pro	CDH3 CDH4	8.57e-04	8	105	2	SM01055
Domain	Cadherin_pro_dom	CDH3 CDH4	8.57e-04	8	105	2	IPR014868
Domain	VPS9	ALS2 RIN1	1.37e-03	10	105	2	PS51205
Domain	Sugar_P_trans_dom	SLC35E2B SLC35E2A	1.37e-03	10	105	2	IPR004853
Domain	VPS9	ALS2 RIN1	1.37e-03	10	105	2	PF02204
Domain	VPS9	ALS2 RIN1	1.37e-03	10	105	2	IPR003123
Domain	TPT	SLC35E2B SLC35E2A	1.37e-03	10	105	2	PF03151
Domain	PP2C_BS	PPM1E PPM1F	1.99e-03	12	105	2	IPR000222
Domain	PP2C_SIG	PPM1E PPM1F	2.73e-03	14	105	2	SM00331
Domain	PPM_1	PPM1E PPM1F	3.13e-03	15	105	2	PS01032
Domain	PP2C	PPM1E PPM1F	4.03e-03	17	105	2	IPR015655
Domain	PP2C	PPM1E PPM1F	5.03e-03	19	105	2	PF00481
Domain	DH_1	ALS2 PLEKHG6 AKAP13	5.37e-03	63	105	3	PS00741
Domain	PP2Cc	PPM1E PPM1F	5.57e-03	20	105	2	SM00332
Domain	-	PPM1E PPM1F	5.57e-03	20	105	2	3.60.40.10
Domain	PPM-type_phosphatase_dom	PPM1E PPM1F	5.57e-03	20	105	2	IPR001932
Domain	PPM_2	PPM1E PPM1F	5.57e-03	20	105	2	PS51746
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DMXL2 ERP44 GNPTAB CTIF ARHGAP35 KIAA0753 HIVEP3 SSH1 CGN SSX2IP PCDH18 UTP14C	4.23e-08	493	107	12	15368895
Pubmed	Structural requirements for the assembly of LINC complexes and their function in cellular mechanical stiffness.	SYNE1 SYNE3 SYNE2	2.82e-07	5	107	3	18396275
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SLC12A6 DMXL2 HIVEP1 SYNE1 HLA-E MAP3K5 OPTN CLIC5 SYNE2 GNL3 MYBPC2	4.10e-07	497	107	11	23414517
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN HIVEP1 DSG2 CEP162 ALS2 KIAA0753 PJA2 OPTN CEP95 SYNE2 CGN SSX2IP AKAP13 PATJ	4.23e-07	861	107	14	36931259
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DMXL2 SYNE1 GNPTAB ALS2 ADGRV1 MED13L ARHGAP35 SYNE2	5.09e-07	225	107	8	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MON2 POGK SYNE1 PPM1E ALS2 GPATCH8 SLC39A10 MED13L WDR47 PJA2	5.53e-07	407	107	10	12693553
Pubmed	Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes.	SYNE1 SYNE3 SYNE2	5.62e-07	6	107	3	33058875
Pubmed	TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.	SYNE1 SYNE3 SYNE2	5.62e-07	6	107	3	18827015
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 CCT3 CEP162 PPM1E HUWE1 SLC39A10 KIAA0753 SSH1 PPM1F SSH3 SYNE2 CGN SSX2IP NBR1 STOML2	7.98e-07	1049	107	15	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN DMXL2 CCT3 SYNE1 KIF4A HUWE1 MAP3K5 WDR47 SSH1 SYNE2 PPP1R3F PARN CABIN1 STOML2	1.58e-06	963	107	14	28671696
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DMXL2 DSG2 SYNE1 BAG4 HEATR1 SLC39A10 KIAA0753 PJA2 SYNE3 SYNE2 SSX2IP AKAP13 TADA3 NBR1 GNL3 STOML2 ATP6V0A2	2.95e-06	1487	107	17	33957083
Pubmed	A conserved KASH domain protein associates with telomeres, SUN1, and dynactin during mammalian meiosis.	SYNE1 SYNE3 SYNE2	4.59e-06	11	107	3	22826121
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	GPHN ERP44 ALS2 HEATR1 HUWE1 ARHGAP35 PJA2 PLEKHG6 SMC3 CGN AKAP13 PATJ STOML2	4.99e-06	916	107	13	32203420
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CCT3 PHRF1 KIF4A HEATR1 HUWE1 MDC1 SYNE2 CGN PARN GNL3 STOML2	5.71e-06	653	107	11	22586326
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ERP44 CEP162 ALS2 HEATR1 HUWE1 GPATCH8 SLC39A10 KIAA0753 VCAN PATJ PCDH18 FHIP2B ATP6V0A2 UTP14C	6.18e-06	1084	107	14	11544199
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 SZT2 HUWE1 MED13L ARHGAP35 SLC35E2B MAP3K5 HIVEP3 SYNE3 SSH1 ZNF827 OSBPL5 AKAP13 CABIN1	7.68e-06	1105	107	14	35748872
Pubmed	Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds.	SYNE1 SYNE2	9.38e-06	2	107	2	22768332
Pubmed	SLC35E2 promoter mutation as a prognostic marker of esophageal squamous cell carcinoma.	SLC35E2B SLC35E2A	9.38e-06	2	107	2	35247439
Pubmed	Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues.	SYNE1 SYNE2	9.38e-06	2	107	2	11792814
Pubmed	Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration.	SYNE1 SYNE2	9.38e-06	2	107	2	24931616
Pubmed	Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation.	SYNE1 SYNE2	9.38e-06	2	107	2	17267447
Pubmed	Nesprins: tissue-specific expression of epsilon and other short isoforms.	SYNE1 SYNE2	9.38e-06	2	107	2	24718612
Pubmed	Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response.	SYNE1 SYNE2	9.38e-06	2	107	2	24586179
Pubmed	Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.	SYNE1 SYNE2	9.38e-06	2	107	2	17761684
Pubmed	Nesprin-1-alpha2 associates with kinesin at myotube outer nuclear membranes, but is restricted to neuromuscular junction nuclei in adult muscle.	SYNE1 SYNE2	9.38e-06	2	107	2	31578382
Pubmed	Cytoskeletal interactions at the nuclear envelope mediated by nesprins.	SYNE1 SYNE3	9.38e-06	2	107	2	22518138
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	PCDHGA10 CEP162 SYNE1 SYNE3 AKAP13 CDH3	1.40e-05	168	107	6	30631154
Pubmed	Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.	PPM1E RFX4 CDH4	1.54e-05	16	107	3	17903297
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PHRF1 ALS2 HUWE1 HIVEP3 PCDH18	1.57e-05	101	107	5	10997877
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MON2 ERP44 KIF4A HUWE1 GPATCH8 MDC1 AKAP13 PRR14L PATJ NBR1 GNL3	1.68e-05	733	107	11	34672954
Pubmed	Syne-1, a dystrophin- and Klarsicht-related protein associated with synaptic nuclei at the neuromuscular junction.	SYNE1 SYNE2	2.81e-05	3	107	2	10878022
Pubmed	Differential activities, subcellular distribution and tissue expression patterns of three members of Slingshot family phosphatases that dephosphorylate cofilin.	SSH1 SSH3	2.81e-05	3	107	2	14531860
Pubmed	The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope.	SYNE1 SYNE2	2.81e-05	3	107	2	16079285
Pubmed	The nesprins are giant actin-binding proteins, orthologous to Drosophila melanogaster muscle protein MSP-300.	SYNE1 SYNE2	2.81e-05	3	107	2	12408964
Pubmed	Distinct functional domains in nesprin-1alpha and nesprin-2beta bind directly to emerin and both interactions are disrupted in X-linked Emery-Dreifuss muscular dystrophy.	SYNE1 SYNE2	2.81e-05	3	107	2	17462627
Pubmed	The LINC-anchored actin cap connects the extracellular milieu to the nucleus for ultrafast mechanotransduction.	SYNE3 SYNE2	2.81e-05	3	107	2	23336069
Pubmed	Structures of FHOD1-Nesprin1/2 complexes reveal alternate binding modes for the FH3 domain of formins.	SYNE1 SYNE2	2.81e-05	3	107	2	33472039
Pubmed	Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells.	SYNE1 SYNE2	2.81e-05	3	107	2	25516977
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	CCT3 DSG2 KIF4A HUWE1 KIAA0753 SMC3 CGN STOML2	3.39e-05	399	107	8	37536630
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	MON2 CTIF TMEM132D MDC1 PRICKLE2 MX1	3.64e-05	199	107	6	23382691
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGDS SZT2 CEP162 PHRF1 ADGRV1 PPM1F MDC1 OSBPL5 NBR1	3.90e-05	529	107	9	14621295
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	BAG4 HEATR1 PJA2 OPTN CEP95 NBR1 CAPN15	4.31e-05	302	107	7	30561431
Pubmed	Functional consequences of necdin nucleocytoplasmic localization.	HUWE1 TADA3 CDH4 PCDH18	4.67e-05	64	107	4	22442722
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GPHN DSG2 KIF4A HEATR1 HUWE1 ARHGAP35 MDC1 CGN PATJ	5.19e-05	549	107	9	38280479
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	MON2 DSG2 HUWE1 GPATCH8 PJA2 STOML2 ATP6V0A2	5.40e-05	313	107	7	38270169
Pubmed	Mammalian sperm head formation involves different polarization of two novel LINC complexes.	SYNE1 SYNE3	5.60e-05	4	107	2	20711465
Pubmed	SUN1 interacts with nuclear lamin A and cytoplasmic nesprins to provide a physical connection between the nuclear lamina and the cytoskeleton.	SYNE1 SYNE2	5.60e-05	4	107	2	16648470
Pubmed	LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina.	SYNE1 SYNE2	5.60e-05	4	107	2	23071752
Pubmed	Ubiquitination and inhibition of glycine receptor by HUWE1 in spinal cord dorsal horn.	GPHN HUWE1	5.60e-05	4	107	2	30721695
Pubmed	Developmental defects in mouse embryos lacking N-cadherin.	CDH3 CDH4	5.60e-05	4	107	2	9015265
Pubmed	Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development.	SYNE1 SYNE2	5.60e-05	4	107	2	20108321
Pubmed	Nesprin-2 interacts with meckelin and mediates ciliogenesis via remodelling of the actin cytoskeleton.	SYNE1 SYNE2	5.60e-05	4	107	2	19596800
Pubmed	The slingshot family of phosphatases mediates Rac1 regulation of cofilin phosphorylation, laminin-332 organization, and motility behavior of keratinocytes.	SSH1 SSH3	5.60e-05	4	107	2	17848544
Pubmed	Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture.	SYNE1 SYNE2	5.60e-05	4	107	2	28716842
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ERP44 CCT3 DSG2 SYNE1 HEATR1 HUWE1 SMC3 MDC1 SYNE2 CGN GNL3 STOML2	7.58e-05	1024	107	12	24711643
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HIVEP1 SYNE1 PCDH11Y OSBPL5 PRICKLE2 PPP1R3F	8.72e-05	233	107	6	37704626
Pubmed	LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins.	SYNE1 SYNE2	9.32e-05	5	107	2	22632968
Pubmed	The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family.	PPM1E PPM1F	9.32e-05	5	107	2	11864573
Pubmed	A human MAP kinase interactome.	RALGDS HIVEP1 CCT3 SYNE1 MAP3K5 SMC3 CEP95 AKAP13	1.34e-04	486	107	8	20936779
Pubmed	The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation.	OPTN NBR1	1.40e-04	6	107	2	33577621
Pubmed	POPX2 phosphatase regulates the KIF3 kinesin motor complex.	PPM1E PPM1F	1.40e-04	6	107	2	24338362
Pubmed	Integrated RAS signaling defined by parallel NMR detection of effectors and regulators.	RALGDS RIN1	1.40e-04	6	107	2	24441586
Pubmed	Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin.	SSH1 SSH3	1.40e-04	6	107	2	11832213
Pubmed	Amyotrophic Lateral Sclerosis Overview	ALS2 OPTN CFAP410	1.44e-04	33	107	3	20301623
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	ERP44 GHDC DSG2 BAG4 HEATR1 HUWE1 PJA2 SMC3 PPM1F NBR1 CAPN15	1.58e-04	942	107	11	31073040
Pubmed	Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling.	CCT3 HUWE1 SLC39A10 PJA2 SMC3	1.67e-04	166	107	5	34687317
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	GPHN POGK KIF4A HUWE1 RIN1 SSH3 AKAP13 PARN	1.69e-04	503	107	8	16964243
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MON2 TDRKH DSG2 POGK BAG4 PHRF1 PJA2 ZNF827 SSX2IP TAF11 TADA3 GNL3	1.69e-04	1116	107	12	31753913
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	MON2 GPHN SLC12A6 TDRKH DMXL2 DSG2 SLC39A10 SYNE2	1.71e-04	504	107	8	34432599
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	HUWE1 OPTN SYNE2 NBR1	1.92e-04	92	107	4	15840729
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	GABRE SLC12A6 PCDH11Y CTIF ADGRV1 HUWE1 ARHGAP35 HIVEP3 ZNF827 OSBPL5 AKAP13 PATJ NBR1 GNL3	1.92e-04	1489	107	14	28611215
Pubmed	Genetic dissection of cadherin function during nephrogenesis.	CDH3 CDH4	1.95e-04	7	107	2	11839813
Pubmed	Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.	RALGDS RIN1	1.95e-04	7	107	2	11788587
Pubmed	Unusual chromatin status and organization of the inactive X chromosome in murine trophoblast giant cells.	KIF4A HUWE1	1.95e-04	7	107	2	23362347
Pubmed	Bridging expressed sequence alignments through targeted cDNA sequencing.	SZT2 HEATR1	2.59e-04	8	107	2	15028280
Pubmed	Critical role of mitochondrial ubiquitination and the OPTN-ATG9A axis in mitophagy.	OPTN NBR1	2.59e-04	8	107	2	32556086
Pubmed	Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition.	GPHN SLC12A6	2.59e-04	8	107	2	11395011
Pubmed	Lulu2 regulates the circumferential actomyosin tensile system in epithelial cells through p114RhoGEF.	CGN PATJ	2.59e-04	8	107	2	22006950
Pubmed	Protein binding and signaling properties of RIN1 suggest a unique effector function.	RALGDS RIN1	2.59e-04	8	107	2	9144171
Pubmed	Biochemical characterization of the Ras-related GTPases Rit and Rin.	RALGDS RIN1	2.59e-04	8	107	2	10545207
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CCT3 KIF4A HEATR1 HUWE1 WDR47 RIN1 SMC3 PPM1F MDC1 AKAP13 PRR14L GNL3 STOML2	2.69e-04	1353	107	13	29467282
Pubmed	The functional interactome landscape of the human histone deacetylase family.	CCT3 HEATR1 HUWE1 SMC3 ZNF827 SYNE2	2.80e-04	289	107	6	23752268
Pubmed	Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.	SYT12 SYNE1 RIN1 GNL3	2.85e-04	102	107	4	21926972
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	POGK PHRF1 OSBPL5 CCDC180	2.96e-04	103	107	4	10819331
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DSG2 CEP162 CTIF PJA2 CEP95 PPM1F CGN SSX2IP GNL3 FHIP2B	3.08e-04	853	107	10	28718761
Pubmed	Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy.	MON2 SLC12A6 HUWE1 OSBPL5	3.31e-04	106	107	4	33087821
Pubmed	Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin.	SSH1 SSH3	3.33e-04	9	107	2	15660133
Pubmed	Coordination of Cellular Dynamics Contributes to Tooth Epithelium Deformations.	SSH1 SSH3	3.33e-04	9	107	2	27588418
Pubmed	Isolation of novel tissue-specific genes from cDNA libraries representing the individual tissue constituents of the gastrulating mouse embryo.	ERP44 CCT3 BAG4 PJA2 TAF11 CFAP44 ATP6V0A2	3.90e-04	432	107	7	7671812
Pubmed	Nuclear membrane proteins with potential disease links found by subtractive proteomics.	SYNE1 SYNE2	4.15e-04	10	107	2	12958361
Pubmed	The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation.	HIVEP1 VCAN	4.15e-04	10	107	2	9076683
Pubmed	Ppm1E is an in cellulo AMP-activated protein kinase phosphatase.	PPM1E PPM1F	4.15e-04	10	107	2	20801214
Pubmed	Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle.	SYNE1 SYNE2	4.15e-04	10	107	2	28533284
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	HUWE1 SMC3	4.15e-04	10	107	2	17478428
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	PGBD1 ALS2 ZKSCAN7 KIAA0753 RIN1 OPTN SSX2IP TADA3 NBR1	4.87e-04	742	107	9	26871637
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	MON2 DMXL2 SMC3 PTX3 SYNE2 CDH4	4.96e-04	322	107	6	26514267
Pubmed	The centrosomal deubiquitylase USP21 regulates Gli1 transcriptional activity and stability.	SYNE1 WDR47	5.06e-04	11	107	2	27621083
Pubmed	delta-Protocadherins: a gene family expressed differentially in the mouse brain.	PCDH11Y CDH4	5.06e-04	11	107	2	15905963
Pubmed	Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease.	OPTN NBR1	5.06e-04	11	107	2	32093570
Pubmed	SPATA7 maintains a novel photoreceptor-specific zone in the distal connecting cilium.	SPATA7 CFAP410	5.06e-04	11	107	2	29899041
Interaction	YWHAH interactions	HIVEP1 DSG2 CEP162 ALS2 HUWE1 MAP3K5 KIAA0753 RIN1 PJA2 OPTN SSH1 CEP95 SYNE2 CGN SSX2IP OSBPL5 AKAP13 PATJ CFAP410	4.96e-06	1102	107	19	int:YWHAH
Interaction	YWHAG interactions	GPHN HIVEP1 DSG2 CEP162 ALS2 HUWE1 MAP3K5 KIAA0753 RIN1 PJA2 OPTN SSH1 CEP95 SYNE2 CGN SSX2IP AKAP13 PATJ NBR1 CFAP410	8.03e-06	1248	107	20	int:YWHAG
Interaction	YWHAZ interactions	DMXL2 HIVEP1 ERP44 DSG2 CEP162 ALS2 HUWE1 MAP3K5 RIN1 OPTN SSH1 CEP95 SSH3 MDC1 SYNE2 CGN SSX2IP AKAP13 PRR14L CFAP410	1.80e-05	1319	107	20	int:YWHAZ
Interaction	ARHGAP40 interactions	ARHGAP35 SYNE2 PRICKLE2 AKAP13	2.41e-05	32	107	4	int:ARHGAP40
Cytoband	11q13.2	SYT12 RIN1 SSH3	1.85e-04	47	107	3	11q13.2
Cytoband	6q25	SYNE1 FNDC1	3.50e-04	12	107	2	6q25
Cytoband	16p13	SNN PARN	4.13e-04	13	107	2	16p13
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE1 SYNE3 SYNE2	2.73e-07	4	75	3	1252
GeneFamily	Slingshot protein phosphatases	SSH1 SSH3	5.08e-05	3	75	2	898
GeneFamily	CD molecules\|Type I classical cadherins	CDH3 CDH4	1.68e-04	5	75	2	1185
GeneFamily	VPS9 domain containing	ALS2 RIN1	7.48e-04	10	75	2	928
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH18	1.09e-03	12	75	2	21
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PPM1E PPM1F	2.22e-03	17	75	2	701
Coexpression	FEVR_CTNNB1_TARGETS_UP	ERP44 SYT12 GHDC DSG2 HLA-E TRIM16 OPTN CLIC5 SLC35E2A SYNE2 CGN ATP6V0A2 CAPN15	4.72e-06	688	107	13	M2342
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	GPHN TDRKH DMXL2 POGK CEP162 GNPTAB PPM1E HUWE1 RFX4 WDR47 CLIC5 SMC3 PTX3 SYNE2 PRR14L CDH4 ZMYM5	6.52e-07	831	105	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	SZT2 POGK CEP162 PRSS22 HIF3A HUWE1 GPATCH8 SSH1 ZNF827 VCAN PRICKLE2 KANK4 AKAP13 PATJ PCDH18	9.94e-06	806	105	15	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	GPHN SPATA7 DMXL2 ERP44 CEP162 GNPTAB HUWE1 CLIC5 CEP95 PTX3 SYNE2 PRR14L ZMYM5 UTP14C	3.01e-05	780	105	14	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	TDRKH PPM1E RFX4 CLIC5 SMC3 SYNE2 CDH4	1.56e-04	232	105	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#2	DSG2 GPATCH8 MAP3K5 SUOX CGN PATJ CDH3 FHIP2B	1.65e-04	313	105	8	Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#4	DSG2 MAP3K5 SUOX CGN OSBPL5 PATJ CDH3 FHIP2B	1.76e-04	316	105	8	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K4
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	TDRKH DMXL2 CCT3 ALS2 HEATR1 GPATCH8 MAP3K5 OPTN CEP95 CABIN1 CDH3 GNL3 ZMYM5	1.80e-04	810	105	13	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	SPATA7 CEP162 PPM1E CTIF HEATR1 ADGRV1 SLC35E2B WDR47 SYNE3 CLIC5 SMC3 SYNE2 CGN SSX2IP CDH4 CFAP410 ZMYM5 FHIP2B	1.86e-04	1414	105	18	facebase_RNAseq_e10.5_Emin_MedNas_2500
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 GNPTAB GPATCH8 SPATA31D1 SYNE2 OSBPL5 MX1	4.50e-07	194	107	7	a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 GNPTAB GPATCH8 SPATA31D1 SYNE2 OSBPL5 MX1	4.50e-07	194	107	7	0abca32c3547a45cebab0bd69c1f7a0002deaa80
ToppCell	PCW_10-12-Epithelial-Epithelial_airway\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 CLIC5 TMEM132D CGN PATJ CDH3	5.17e-07	198	107	7	9a12e5e47236433e512c668005fe3f8be6fde95c
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC35E2B PLEKHG6 SUOX SSX2IP CDH3 ZNF697	6.07e-06	187	107	6	22fd1959879705a8c1128faa9de66696c4e0b7e3
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC35E2B PLEKHG6 SUOX SSX2IP CDH3 ZNF697	6.07e-06	187	107	6	5fae538de481367cf6d9a2d52190d77b99f6922c
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 ADGRV1 MAP3K5 SYNE2 CGN PATJ	6.07e-06	187	107	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC35E2B PLEKHG6 SUOX SSX2IP CDH3 ZNF697	6.07e-06	187	107	6	0526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ CDH3	6.26e-06	188	107	6	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 HIVEP3 SYNE2 PRICKLE2 PATJ CDH3	6.45e-06	189	107	6	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 HIVEP3 SYNE2 PRICKLE2 PATJ CDH3	6.45e-06	189	107	6	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ CDH3	6.65e-06	190	107	6	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMXL2 HIVEP1 SNN PTX3 VCAN ZNF697	6.85e-06	191	107	6	0b296404ebad0aadb75737f8c0462ec6934fc8bb
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN MED13L SYNE2 PRICKLE2 AKAP13 PATJ	7.06e-06	192	107	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 CLIC5 TMEM132D CGN CDH3	7.27e-06	193	107	6	b38aaffbea36ef6c08ebe82675438f873c89b242
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2 OSBPL5	7.27e-06	193	107	6	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	PCW_13-14-Epithelial-Epithelial_airway\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 CLIC5 TMEM132D CGN CDH3	7.49e-06	194	107	6	7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2 OSBPL5	7.49e-06	194	107	6	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ CDH3	7.49e-06	194	107	6	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ CDH3	7.49e-06	194	107	6	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ CDH3	7.71e-06	195	107	6	d67a2b489c29bfd575751c13d2a5b1efdec5240a
ToppCell	PCW_10-12-Epithelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ CDH3	7.94e-06	196	107	6	9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	DMXL2 HLA-E MED13L SNN AKAP13 MX1	8.41e-06	198	107	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	URO-Lymphocyte-T_NK-NK\|URO / Disease, Lineage and Cell Type	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2 OSBPL5	8.41e-06	198	107	6	2ccff882aafabf041df15b31d9abc50dcbc2696e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	b03539908131308d7bf5036e78c4c840a6a79a17
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GPATCH8 CEP95 VCAN AKAP13 CABIN1 UTP14C	8.66e-06	199	107	6	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	mild_COVID-19_(asymptomatic)-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	DMXL2 MED13L SNN HIVEP3 VCAN MX1	8.66e-06	199	107	6	727122b6f4ca265d2826c9271b10a4215a9d45a3
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	7d071c88a003babf6dbdb84dde561fc03c92f375
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	5e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	mild_COVID-19-NK\|mild_COVID-19 / disease group, cell group and cell class (v2)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	4854f25ee436e1cf577744373ffd87b1221d2b88
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.66e-06	199	107	6	d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCell	remission-CD8+_Tem\|World / disease stage, cell group and cell class	RALGDS SYNE1 HLA-E OPTN SYNE2 AKAP13	8.91e-06	200	107	6	0ebf0dda91fc7adb9ea69734ad9dcc65d0082c6d
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	SYNE1 GNPTAB HLA-E OPTN SYNE2 OSBPL5	8.91e-06	200	107	6	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 GNPTAB OPTN SYNE2 OSBPL5 MX1	8.91e-06	200	107	6	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	Sepsis-URO-Lymphocyte-T/NK-NK\|URO / Disease, condition lineage and cell class	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2 OSBPL5	8.91e-06	200	107	6	741c7bad606c7e4d7db57d89aaf4dcf4232fa82a
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SYNE1 GNPTAB HLA-E HUWE1 SYNE2 MX1	8.91e-06	200	107	6	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK\|Leuk-UTI / Disease, condition lineage and cell class	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2 OSBPL5	8.91e-06	200	107	6	bb37fed4872e71f413ae7c4aa12586fa31075334
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 FNDC1 SYNE3 SYNE2 MX1	9.78e-06	118	107	5	5f72022f4be3fb7ccec86dc05d37572833028886
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SYNE1 FNDC1 SYNE3 SYNE2 MX1	9.78e-06	118	107	5	053c0986051e36fdc4c48b8067c137b6299b2f1b
ToppCell	Control-Lymphoid_T/NK-NK_activated\|Control / Disease group, lineage and cell class	SYNE1 FNDC1 SYNE3 SYNE2 MX1	1.02e-05	119	107	5	a258d91ac90d4174b6f203d7f96ba6e57c6003e7
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 FNDC1 SYNE3 SYNE2 MX1	1.02e-05	119	107	5	28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 FNDC1 SYNE3 SYNE2 MX1	1.02e-05	119	107	5	0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	SYNE1 PPM1E FNDC1 SYNE2 AKAP13	1.88e-05	135	107	5	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	HIF3A SLC9A2 CABS1 CDH3 MYBPC2	3.42e-05	153	107	5	151c469b26f9adf04dd6f117f03bef760cc3d45d
ToppCell	Basal_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ZKSCAN7 SUOX SLC35E2A SSX2IP PPP1R3F	4.77e-05	164	107	5	b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c
ToppCell	droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GHDC CEP162 ZNF827 SSH3 OSBPL5	4.91e-05	165	107	5	8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRIM16 OPTN SYNE2 PPP1R3F MX1	4.91e-05	165	107	5	dbe231d00843cae917efd1abea6079ace3b45cdf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRIM16 OPTN SYNE2 PPP1R3F MX1	4.91e-05	165	107	5	9ccce713d4122054bf4bef4a7126d90cf9141b84
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 CLIC5 TMEM132D PRICKLE2 PATJ	5.05e-05	166	107	5	c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1\|TCGA-Uvea / Sample_Type by Project: Shred V9	PPM1F SSH3 OSBPL5 CABIN1 CFAP410	5.35e-05	168	107	5	b427746929bb40e3d1b5f1c40d302b792d6b32a5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 CLIC5 SYNE2 PRICKLE2 PATJ	5.65e-05	170	107	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRV1 RFX4 KIAA0753 PATJ CAPN15	6.14e-05	173	107	5	23e50492bc673aff9df95d97f0b9be4ce57cbf01
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SLC12A6 DMXL2 HEATR1 SUOX PPP1R3F	6.14e-05	173	107	5	efb8072475000888efe088d00e870c56ffad4172
ToppCell	IIH-CD8-naive_CD4\|IIH / Condition, Cell_class and T cell subcluster	GHDC ZNF827 CFAP44 ATP6V0A2 CAPN15	6.14e-05	173	107	5	4f2843371d18af766c1892529ce286f56c956fde
ToppCell	droplet-Marrow-nan-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TDRKH CTIF SLC39A10 ARHGAP35 MX1	6.31e-05	174	107	5	55cc8300489d11322724159ec7d0e1d32a702e91
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SLC12A6 DMXL2 HEATR1 SUOX PPP1R3F	6.31e-05	174	107	5	58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 GNPTAB HLA-E SYNE2 MX1	6.84e-05	177	107	5	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 GNPTAB HLA-E SYNE2 MX1	6.84e-05	177	107	5	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMXL2 SYT12 PRSS22 MAP3K5 CDH3	6.84e-05	177	107	5	e1e45956887371b1c18f1eb479dd930031497520
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	SYNE1 GNPTAB HLA-E SYNE2 MX1	6.84e-05	177	107	5	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 GNPTAB HLA-E SYNE2 MX1	6.84e-05	177	107	5	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SYNE1 GNPTAB HLA-E SYNE2 MX1	6.84e-05	177	107	5	d5aeda113afaa2425874394610344570c9078478
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TDRKH FNDC1 KANK4 GJC3 MYBPC2	7.03e-05	178	107	5	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	severe-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYNE1 ALS2 SLC39A10 SYNE2 PATJ	7.41e-05	180	107	5	ac03812b1409435c55d323a7516deeac82bd3509
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STX2 SYNE1 KIF4A OPTN SYNE2	7.61e-05	181	107	5	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STX2 SYNE1 KIF4A OPTN SYNE2	7.61e-05	181	107	5	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMXL2 SNN PTX3 VCAN ZNF697	7.81e-05	182	107	5	c3eafdc11858566aa7692b2f5dbe72ac01fb769a
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN CDH3	8.01e-05	183	107	5	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	normal_Lymph_Node-Myeloid_cells-Monocytes\|normal_Lymph_Node / Location, Cell class and cell subclass	DMXL2 PTX3 VCAN RNASE10 ZNF697	8.22e-05	184	107	5	3cec28ff076fa53d034428de2bb1a237e0c1568c
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	FNDC1 CLIC5 CGN KANK4 CDH4	8.22e-05	184	107	5	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	FNDC1 CLIC5 CGN KANK4 CDH4	8.22e-05	184	107	5	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 CLIC5 TMEM132D PRICKLE2 PATJ	8.43e-05	185	107	5	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MON2 DMXL2 GNPTAB HEATR1 HUWE1	8.43e-05	185	107	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM16 CLIC5 PPM1F PRICKLE2 ZNF697	8.65e-05	186	107	5	9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MON2 DMXL2 GNPTAB HEATR1 HUWE1	8.65e-05	186	107	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADGRV1 TRIM16 FNDC1 PTX3 VCAN	8.87e-05	187	107	5	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 GNPTAB OPTN SYNE2 OSBPL5	8.87e-05	187	107	5	0bca79cea4886b66350c56c61859bd71e1e7a85c
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTIF TRIM16 CLIC5 PPM1F PRICKLE2	9.09e-05	188	107	5	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ	9.09e-05	188	107	5	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	droplet-Limb_Muscle-nan-3m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GHDC PJA2 CLIC5 PRICKLE2 ATP6V0A2	9.32e-05	189	107	5	16a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 TMEM132D CGN PATJ CDH3	9.32e-05	189	107	5	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MON2 GPHN MAP3K5 SYNE2 AKAP13	9.32e-05	189	107	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2	9.56e-05	190	107	5	1f890be1ac8613a098b271945f25a58c3c2530ab
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 GNPTAB HLA-E GPATCH8 SYNE2	9.56e-05	190	107	5	d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCell	COPD-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	GPHN SLC12A6 HIVEP1 MAP3K5 SYNE2	9.80e-05	191	107	5	3ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN PATJ	9.80e-05	191	107	5	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN CDH3	9.80e-05	191	107	5	05731ece7867659c662f952812805f947032fe10
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MON2 GNPTAB HEATR1 HUWE1 SYNE3	9.80e-05	191	107	5	9454f642c3621370fa23640b631301346b300950
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN CDH3	9.80e-05	191	107	5	63aa671837b79d2feb7ed1e67712cc01caf72bef
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	SYNE1 GNPTAB SYNE2 OSBPL5 KANK4	9.80e-05	191	107	5	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MON2 HIVEP1 HIF3A MED13L VCAN	1.00e-04	192	107	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 GNPTAB HLA-E OPTN SYNE2	1.00e-04	192	107	5	fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCell	ASK452-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	SYNE1 ADGRV1 SYNE2 OSBPL5 TADA3	1.00e-04	192	107	5	f04ee5aaa54c39b7493098fb3d2f78168d6b8060
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 TMEM132D CGN CDH3	1.00e-04	192	107	5	b73f24d1c55dfef1eb01c26da117dbf637ea080a
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS22 ADGRV1 CLIC5 TMEM132D CDH3	1.00e-04	192	107	5	450baeb5c3df7a9445472530002ce38f177a333c
ToppCell	CD8+_Memory_T_cell-CV-0\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	RALGDS SYNE1 HLA-E SYNE2 AKAP13	1.03e-04	193	107	5	995781d87a919c0380750878bafe584342bb83ad
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	STX2 TDRKH ERP44 SSH3 AKAP13 PRR14L CABIN1 TADA3 FHIP2B	3.59e-07	195	107	9	3508_DN
Drug	Tyloxapol [25301-02-4]; Down 200; 4uM; PC3; HT_HG-U133A	SLC12A6 ERP44 BAG4 ARHGAP35 KIAA0753 SLC9A2 AKAP13 ZMYM5 MX1	3.59e-07	195	107	9	4611_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	RALGDS SYNE1 ARHGAP35 PLEKHG6 AKAP13 CABIN1 TADA3 CFAP410 CAPN15	4.26e-07	199	107	9	4297_DN
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	SLC12A6 TDRKH NPR2 ARHGAP35 OPTN PRR14L PATJ CABIN1 CFAP410	4.26e-07	199	107	9	1472_DN
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A	SZT2 BAG4 MED13L SSH3 CABIN1 CFAP410 ZMYM5 CAPN15	3.27e-06	190	107	8	7070_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	NPR2 CEP162 MED13L MAP3K5 PPM1F SSH3 CABIN1 CFAP410	3.81e-06	194	107	8	2824_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	SLC12A6 ARHGAP35 RIN1 OPTN PPM1F SSX2IP PATJ ATP6V0A2	3.81e-06	194	107	8	1707_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	RALGDS ERP44 CTIF SNN SSH3 PRR14L CABIN1 CAPN15	3.96e-06	195	107	8	3530_DN
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A	STX2 ERP44 PCDHGA10 CEP162 ARHGAP35 SLC9A2 SSH3 PATJ	4.11e-06	196	107	8	6305_UP
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SPATA7 ERP44 BAG4 MED13L SNN MAP3K5 CABIN1 TADA3	4.11e-06	196	107	8	2829_DN
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A	SPATA7 STX2 BAG4 PRSS22 MAP3K5 SSH3 SSX2IP PRR14L	4.43e-06	198	107	8	5487_DN
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	SPATA7 STX2 ARHGAP35 MAP3K5 SLC9A2 AKAP13 PRR14L ZMYM5	4.43e-06	198	107	8	3418_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	RALGDS MAP3K5 KIAA0753 SSH1 VCAN AKAP13 MX1	3.37e-05	191	107	7	6644_DN
Drug	valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SLC12A6 TDRKH SYT12 CEP162 CTIF PPM1F MX1	3.37e-05	191	107	7	5957_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	STX2 DMXL2 SZT2 HIVEP3 AKAP13 CABIN1 CAPN15	3.72e-05	194	107	7	4763_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; PC3; HT_HG-U133A	RALGDS CEP162 MAP3K5 SSH3 VCAN PATJ ZMYM5	3.72e-05	194	107	7	6729_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; HL60; HT_HG-U133A	DMXL2 SYNE1 PPM1E MED13L RIN1 VCAN MX1	3.84e-05	195	107	7	2916_DN
Drug	carmustine; Up 200; 100uM; MCF7; HT_HG-U133A	STX2 DMXL2 CEP162 BAG4 ARHGAP35 PPM1F PATJ	3.97e-05	196	107	7	6888_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	HIVEP1 PRSS22 ARHGAP35 OPTN PPM1F AKAP13 PATJ	3.97e-05	196	107	7	5523_DN
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; MCF7; HT_HG-U133A	NPR2 HIVEP1 PRSS22 SLC9A2 SSX2IP CFAP410 ZMYM5	3.97e-05	196	107	7	2630_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RALGDS SZT2 BAG4 SSX2IP PATJ CABIN1 FHIP2B	3.97e-05	196	107	7	7357_DN
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A	STX2 ERP44 ARHGAP35 RIN1 SLC9A2 AKAP13 CFAP410	3.97e-05	196	107	7	4587_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A	CEP162 SYNE1 RIN1 OPTN CLIC5 SSH3 CAPN15	3.97e-05	196	107	7	3095_DN
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A	MON2 NPR2 SZT2 GNPTAB HIVEP3 CLIC5 MX1	3.97e-05	196	107	7	3380_UP
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	SLC12A6 ARHGAP35 RIN1 AKAP13 MX1 FHIP2B CAPN15	4.10e-05	197	107	7	1803_DN
Drug	Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	ERP44 HUWE1 ARHGAP35 HIVEP3 OPTN SSH3 TMPRSS11D	4.10e-05	197	107	7	5045_UP
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A	DMXL2 SZT2 CEP162 CTIF KIAA0753 SSH3 CFAP410	4.10e-05	197	107	7	2532_DN
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; PC3; HT_HG-U133A	NPR2 BAG4 MAP3K5 SSH3 VCAN CABIN1 ZMYM5	4.10e-05	197	107	7	7153_UP
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	CEP162 CTIF HIF3A ARHGAP35 HIVEP3 SSH3 CFAP410	4.23e-05	198	107	7	2392_DN
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	RALGDS ERP44 CEP162 CTIF RIN1 SSX2IP PATJ	4.23e-05	198	107	7	4703_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	RALGDS SYNE1 CTIF HIVEP3 RIN1 SLC9A2 CABIN1	4.23e-05	198	107	7	4005_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A	BAG4 CTIF HIF3A KIAA0753 VCAN TADA3 CAPN15	4.23e-05	198	107	7	2401_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	NPR2 ARHGAP35 SSH3 CABIN1 CFAP410 MX1 CAPN15	4.23e-05	198	107	7	5731_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	RALGDS CEP162 SYNE1 MED13L ARHGAP35 SMC3 PRR14L	4.23e-05	198	107	7	2124_UP
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A	SZT2 CEP162 KIAA0753 SSH1 SSH3 SSX2IP CAPN15	4.23e-05	198	107	7	2345_UP
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A	GPHN RALGDS CEP162 CTIF HIF3A CFAP44 TADA3	4.37e-05	199	107	7	2400_DN
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A	STX2 MAP3K5 HIVEP3 PPM1F SSH3 VCAN CABIN1	4.37e-05	199	107	7	6693_DN
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A	SYT12 ARHGAP35 MAP3K5 OPTN PPM1F TADA3 CAPN15	4.37e-05	199	107	7	5333_UP
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; PC3; HT_HG-U133A	ARHGAP35 OPTN VCAN AKAP13 PATJ MX1 CAPN15	4.37e-05	199	107	7	4552_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	STX2 SZT2 PRSS22 SSH3 PATJ CFAP410 MX1	4.51e-05	200	107	7	5830_UP
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A	ERP44 HIVEP3 RIN1 SSH3 VCAN AKAP13 PRR14L	4.51e-05	200	107	7	5842_DN
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	STX2 CEP162 SYNE1 SLC9A2 AKAP13 CABIN1 ZMYM5	4.51e-05	200	107	7	6612_DN
Drug	DB75	SYNE1 TMPRSS11D GNL3	9.26e-05	19	107	3	CID000126437
Drug	pridinol	GNPTAB HUWE1 TMPRSS11D	1.09e-04	20	107	3	CID000004904
Drug	NSC290205	TMEM132D MX1	1.30e-04	4	107	2	CID000359501
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A_EA	STX2 PPM1E SNN WDR47 OPTN AKAP13	1.64e-04	172	107	6	1058_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TDRKH PPM1E SNN WDR47 OPTN PLEKHG6	1.80e-04	175	107	6	2835_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA	STX2 PPM1E SNN WDR47 OPTN AKAP13	1.91e-04	177	107	6	1072_UP
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	STX2 TDRKH PPM1E SNN WDR47 OPTN	1.91e-04	177	107	6	1645_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	STX2 CEP162 PPM1E SNN WDR47 OPTN	1.91e-04	177	107	6	7324_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	STX2 PPM1E SNN WDR47 OPTN AKAP13	2.03e-04	179	107	6	1112_UP
Drug	oxomolybdenum	GPHN SUOX	2.17e-04	5	107	2	CID000139765
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA	STX2 PPM1E SNN MAP3K5 OPTN AKAP13	2.58e-04	187	107	6	1047_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	STX2 CEP162 CTIF ARHGAP35 MAP3K5 CABIN1	2.65e-04	188	107	6	1023_UP
Drug	retinoic acid; Down 200; 1uM; HL60; HT_HG-U133A	ARHGAP35 PTX3 SSH3 VCAN SSX2IP MX1	2.73e-04	189	107	6	6170_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SYT12 GPATCH8 RIN1 SLC9A2 SMC3 ZMYM5	2.89e-04	191	107	6	6020_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	MON2 SLC12A6 ERP44 BAG4 RIN1 PRR14L	2.97e-04	192	107	6	6808_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	ARHGAP35 SLC9A2 SMC3 AKAP13 PRR14L CABIN1	2.97e-04	192	107	6	4104_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A	RALGDS DMXL2 KIAA0753 PPM1F VCAN CAPN15	2.97e-04	192	107	6	1332_UP
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A	STX2 TDRKH ARHGAP35 SNN PPM1F CABIN1	3.05e-04	193	107	6	5608_DN
Drug	Pivampicillin [33817-20-8]; Down 200; 8.6uM; PC3; HT_HG-U133A	STX2 MED13L SSH3 VCAN CABIN1 CAPN15	3.05e-04	193	107	6	5046_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A	RALGDS NPR2 HIVEP1 BAG4 ARHGAP35 PATJ	3.05e-04	193	107	6	4650_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	TDRKH ERP44 SMC3 AKAP13 PRR14L MX1	3.14e-04	194	107	6	4320_DN
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	SYT12 SLC9A2 AKAP13 PATJ TADA3 CAPN15	3.14e-04	194	107	6	5384_DN
Drug	Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	STX2 TDRKH ARHGAP35 PRR14L CABIN1 CFAP410	3.14e-04	194	107	6	5755_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A	RALGDS BAG4 HIF3A SUOX SSH3 CAPN15	3.14e-04	194	107	6	2397_DN
Drug	2 rF2	SYNE1 ZKSCAN7 PJA2 MX1	3.15e-04	69	107	4	CID011984575
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	STX2 TDRKH SZT2 SYNE1 VCAN ZMYM5	3.22e-04	195	107	6	7058_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	ERP44 CTIF KIAA0753 CABIN1 TADA3 CAPN15	3.22e-04	195	107	6	1296_DN
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A	SZT2 CTIF HUWE1 HIVEP3 CFAP410 MX1	3.22e-04	195	107	6	1517_UP
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	TDRKH CEP162 PRSS22 CABIN1 CFAP44 ZMYM5	3.22e-04	195	107	6	4740_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; PC3; HT_HG-U133A	MON2 CTIF ARHGAP35 MAP3K5 CFAP410 CAPN15	3.22e-04	195	107	6	6635_DN
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; MCF7; HT_HG-U133A	ARHGAP35 MAP3K5 SSH1 SMC3 PRR14L CAPN15	3.22e-04	195	107	6	1520_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	STX2 PRSS22 MAP3K5 HIVEP3 VCAN AKAP13	3.22e-04	195	107	6	7309_UP
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A	STX2 CEP162 SSH3 VCAN CABIN1 MX1	3.22e-04	195	107	6	5744_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	NPR2 SZT2 CEP162 RIN1 VCAN AKAP13	3.22e-04	195	107	6	3721_DN
Drug	Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A	DMXL2 NPR2 PCDHGA10 CTIF RIN1 CAPN15	3.22e-04	195	107	6	3321_UP
Drug	Beta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A	PCDHGA10 SYNE1 ARHGAP35 CABIN1 TADA3 ZMYM5	3.22e-04	195	107	6	4073_DN
Drug	Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A	GPHN NPR2 ARHGAP35 SSX2IP CABIN1 FHIP2B	3.31e-04	196	107	6	7419_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	MON2 STX2 NPR2 ARHGAP35 SSH3 VCAN	3.31e-04	196	107	6	4472_DN
Drug	Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A	STX2 DMXL2 PRSS22 ARHGAP35 SSH3 AKAP13	3.31e-04	196	107	6	2798_DN
Drug	Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A	NPR2 CEP162 BAG4 CFAP44 CFAP410 CAPN15	3.31e-04	196	107	6	3448_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	CEP162 BAG4 CTIF SNN AKAP13 TADA3	3.31e-04	196	107	6	4718_DN
Drug	5152487; Down 200; 10uM; MCF7; HT_HG-U133A_EA	RALGDS CEP162 SLC9A2 SSH3 CABIN1 ZMYM5	3.31e-04	196	107	6	896_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A	SLC12A6 STX2 CEP162 GPATCH8 ARHGAP35 HIVEP3	3.31e-04	196	107	6	490_UP
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	CEP162 SYNE1 SLC9A2 PTX3 CABIN1 ZMYM5	3.31e-04	196	107	6	4590_DN
Drug	Gliclazide [21187-98-4]; Up 200; 12.4uM; HL60; HG-U133A	ERP44 DSG2 GNPTAB ARHGAP35 PPM1F CFAP410	3.31e-04	196	107	6	1720_UP
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; HL60; HT_HG-U133A	MON2 DMXL2 PPM1F SSH3 AKAP13 CAPN15	3.40e-04	197	107	6	1310_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; HL60; HT_HG-U133A	NPR2 POGK HIVEP3 SSX2IP PARN TADA3	3.40e-04	197	107	6	2439_DN
Drug	Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A	TDRKH CTIF HUWE1 VCAN PATJ MX1	3.40e-04	197	107	6	5866_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A	ARHGAP35 SLC9A2 VCAN CABIN1 TADA3 CAPN15	3.40e-04	197	107	6	4207_DN
Drug	16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; MCF7; HT_HG-U133A	MON2 TDRKH SZT2 CEP162 ZMYM5 CAPN15	3.40e-04	197	107	6	6597_DN
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	SLC12A6 SYT12 ARHGAP35 PLEKHG6 AKAP13 PATJ	3.40e-04	197	107	6	1508_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; PC3; HT_HG-U133A	RALGDS CTIF ARHGAP35 HIVEP3 PLEKHG6 CABIN1	3.40e-04	197	107	6	4017_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SLC12A6 STX2 SZT2 SYNE1 SNN CFAP410	3.40e-04	197	107	6	4764_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A	SYNE1 BAG4 ARHGAP35 KIAA0753 CABIN1 FHIP2B	3.40e-04	197	107	6	4608_DN
Drug	Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	STX2 TDRKH SZT2 PCDHGA10 HIVEP3 MX1	3.40e-04	197	107	6	2821_UP
Drug	Aminocaproic acid [60-32-2]; Up 200; 30.4uM; PC3; HT_HG-U133A	SZT2 SLC9A2 VCAN AKAP13 CABIN1 TADA3	3.40e-04	197	107	6	7258_UP
Drug	3-hydroxy-(D/L)-kynurenine; Up 200; 9.2uM; MCF7; HT_HG-U133A_EA	SPATA7 STX2 GPATCH8 ARHGAP35 WDR47 SMC3	3.40e-04	197	107	6	1109_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TDRKH SYT12 CTIF CLIC5 VCAN TADA3	3.40e-04	197	107	6	4764_UP
Disease	nevus count, cutaneous melanoma	ADGRV1 MED13L SYNE2 CDH3 FHIP2B	1.72e-05	91	103	5	EFO_0000389, EFO_0004632
Disease	cutaneous melanoma, hair color	ADGRV1 MED13L SYNE2 CDH3	6.69e-05	62	103	4	EFO_0000389, EFO_0003924
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	7.21e-05	4	103	2	cv:CN293514
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	1.20e-04	5	103	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 SYNE2	1.20e-04	5	103	2	C0410190
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	1.79e-04	6	103	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 SYNE2	1.79e-04	6	103	2	C0410189
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	2.51e-04	7	103	2	C0751337
Disease	volumetric bone mineral density	CTIF ADGRV1 SMC3	4.30e-04	42	103	3	EFO_0007620
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE1 SYNE2	7.78e-04	12	103	2	DOID:11726 (implicated_via_orthology)
Disease	cutaneous melanoma	ADGRV1 MED13L SYNE2 FHIP2B	8.70e-04	121	103	4	EFO_0000389
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP1 HIVEP3	9.18e-04	13	103	2	DOID:0050787 (implicated_via_orthology)
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 CLIC5	9.18e-04	13	103	2	C1846647
Disease	response to olanzapine	HIVEP1 ADGRV1	1.23e-03	15	103	2	GO_0097333
Disease	inherited metabolic disorder (is_implicated_in)	GPHN SUOX	1.23e-03	15	103	2	DOID:655 (is_implicated_in)
Disease	Amyotrophic lateral sclerosis	ALS2 OPTN	1.59e-03	17	103	2	cv:C0002736
Disease	autism spectrum disorder symptom	SSX2IP PATJ	2.91e-03	23	103	2	EFO_0005426

Protein segments in the cluster

Peptide	Gene	Start	Entry
ARSEDDGIGIEELDT	TADA3	31	O75528
LELDSVETGGQDSVR	BAG4	421	O95429
REDTLLTDEETTEGA	CABS1	281	Q96KC9
VTEEELSRALSEGEE	CFAP410	126	O43822
TLGEEDDEDRTLTVG	VCAN	551	P13611
SEAGSSRSQEIEELE	CTIF	11	O43310
SLVDIREEETEGGSR	ALS2	466	Q96Q42
ERVDDSTGTVISDVE	SSX2IP	301	Q9Y2D8
GEERVDSLVSLSEED	AKAP13	1636	Q12802
SEESQSGLELREGAV	ADGRV1	5371	Q8WXG9
EVLNETIQEGGTRED	NPR2	346	P20594
DEGEDNSSTVSIVGR	DMXL2	1056	Q8TDJ6
SGTSTARSVEEVEEE	CCDC180	686	Q9P1Z9
DAGGSVTIQEESIIE	CFAP44	1086	Q96MT7
GEETSLASVQSEDRG	CLIC5	66	Q9NZA1
GEGSTAEVREEIILT	RFX4	486	Q33E94
QVEDTELIRESDDGT	GPHN	426	Q9NQX3
GVSGEISDTELEQTD	PARN	581	O95453
EDNGEISIGATIDRE	PCDH18	81	Q9HCL0
SVLEEEATEGGTSRV	CAPN15	296	O75808
TLTVEARDGNGEVTD	DSG2	236	Q14126
EEETLIQGREGNTDV	GJC3	111	Q8NFK1
DGEGHTQDTELVETR	HLA-E	241	P13747
SQDGQESVTERERIG	MED13L	1646	Q71F56
ERQTDVTGEEELTKG	MDC1	841	Q14676
EVDTDQSGVLSDREI	GNPTAB	1016	Q3T906
QLNRVVGGEDSTDSE	PRSS22	46	Q9GZN4
LERGEEQEQSETEEG	GPATCH8	1166	Q9UKJ3
AETEELDGGTTESNL	FHIP2B	231	Q86V87
LTVTATDRDEGANGE	PCDHGA10	266	Q9Y5H3
LDQTLSVRGEDIGED	GHDC	386	Q8N2G8
SEDDGETLLEVAGTQ	PHRF1	76	Q9P1Y6
VCQIVTTEGSDGEER	GABRE	406	P78334
ELGELETECQTTTEE	MON2	506	Q7Z3U7
ITRLEGEEESQNSDE	POGK	96	Q9P215
TIIVSRSGEDESQED	HUWE1	2366	Q7Z6Z7
ETDGTEGTVEIETVK	PPM1E	186	Q8WY54
EEEEEGGLSTQQCRT	PRICKLE2	506	Q7Z3G6
EDGASERGNVVVETL	PLEKHG6	671	Q3KR16
EERGKNEESLESTEG	CABIN1	1431	Q9Y6J0
QSTEITGEEELGSRE	FNDC1	536	Q4ZHG4
ETGDIVTVAAGLDRE	CDH4	336	P55283
GNEEVEDGTEETLSQ	CEP95	406	Q96GE4
SSLGVGLDTLEEQEE	CEP162	116	Q5TB80
REITFENGEELTEEG	ERP44	246	Q9BS26
ESSTQEIGEELINGV	RALGDS	61	Q12967
ETGEALSEETTAGEQ	GNL3	511	Q9BVP2
SLTEVRGQVSESEDS	KIF4A	801	O95239
STELRIEEAGTEQEG	KANK4	496	Q5T7N3
DSGDSIEVSRNVEEI	HEATR1	1361	Q9H583
RLTSIGSDEDEETET	SLC12A6	1026	Q9UHW9
GTDDSVVSEDRLNET	SLC39A10	566	Q9ULF5
DSGQVTAVGTLDRED	CDH3	491	P22223
GTVLSQEEVEGELAE	PPM1F	46	P49593
VGEQSEELVTRETGD	PRR14L	1351	Q5THK1
LIRIEEDTGEIFTTG	PCDH11Y	106	Q9BZA8
SVLSNEEIRETGGAE	PTX3	341	P26022
LGELGEASQVETVSE	OSBPL5	351	Q9H0X9
RSEIETQTEGSTEKE	OPTN	271	Q96CV9
NTITEEKGRSTEEGD	MAP3K5	651	Q99683
TGIVDDSTGEILFDE	SZT2	106	Q5T011
GIDEDERNVSTGVVE	SYT12	241	Q8IV01
RDIREQSETTAEGGQ	RIN1	746	Q13671
DGQVSGLTEERTAEQ	TEX55	131	Q96M34
ELNELRETEGGTVLT	SMC3	846	Q9UQE7
ISQSEDEESIVGDGE	SNN	41	O75324
LTVTEVEGLAEGTED	SYNE1	5816	Q8NF91
RTTEGEEETESRVPG	SYNE2	6806	Q8WXH0
SVEDDGTVTELLESV	TMEM132D	456	Q14C87
RGEESLETLEEQSAG	SYNE3	271	Q6ZMZ3
EERQLGEVTEQTEGT	NBR1	516	Q14596
GELESQDVSDLTTVE	TAF11	56	Q15544
SSEDEDEGVELLGVR	HIF3A	576	Q9Y2N7
DGGTDENVLTVTITE	SLC35E2A	46	P0CK97
IEISRTQDEEVGDGT	CCT3	81	P49368
TQDEEVGDGTTSVII	CCT3	86	P49368
LDESVGTEEGSEKRE	KIAA0753	856	Q2KHM9
SGEEAVTVLENLETG	PGBD1	111	Q96JS3
TEGEEIAQEIDGRFT	ARHGAP35	906	Q9NRY4
QLEITGRTTTDDELE	STX2	151	P32856
SGSLLQVEETEREEG	SSH1	581	Q8WYL5
VSTREGEGLSQDETV	SSH3	131	Q8TE77
GLQRELEETSEETGH	CGN	556	Q9P2M7
TLSEQRILGGTEAEE	TMPRSS11D	181	O60235
TGEEITESEVLLGID	WDR47	216	O94967
LQVASESEEEEGGTE	UTP14C	336	Q5TAP6
QTGARIDVDTEDVGD	TDRKH	81	Q9Y2W6
TEEGDGTQTTETLVL	RNASE10	56	Q5GAN6
DQSGSEREDSLTEGI	SLC9A2	771	Q9UBY0
LTGAVETETNVDGED	PATJ	481	Q8NI35
TDNDLTESVRTTEDG	SPATA31D1	1071	Q6ZQQ2
QETGVLEELEAEEGT	HIVEP3	1811	Q5T1R4
LTDRETSVNVIEGDS	SPATA7	531	Q9P0W8
LGEAGTEAQIEVTSE	PPP1R3F	666	Q6ZSY5
DGGTDENVLTVTITE	SLC35E2B	46	P0CK96
ESEGTRESAINVAEG	STOML2	206	Q9UJZ1
EGQLSEEEGVSVRGE	ZNF697	76	Q5TEC3
VSRQEEAEGELSEGE	ZNF827	16	Q17R98
TIVIDDEEDIETNGG	ZMYM5	116	Q9UJ78
ELEGQTSDEEGSRLE	ZKSCAN7	321	Q9P0L1
EEEDVGSSEKLGRET	TRIM16	41	O95361
EPRDGETVESGEVTI	SUOX	431	P51687
SLQEGEQTSLEEGEI	PJA2	486	O43164
DLGVSVGLIDEQDTE	HIVEP1	2146	P15822
EEEVSLLGSQDIEEG	ATP6V0A2	696	Q9Y487
DGFEEIIISESRSES	NLRP13	311	Q86W25
QGEETVGEEDIRLFT	MX1	391	P20591
GDEVFTTTEGRTRIE	MYBPC2	581	Q14324